Key facts
- Hugemed’s last known valuation is $351.9M (Sep 2025).
- It has raised $22.4M; the latest was Later Stage VC in Mar 2026.
- Notable investors include Shenzhen Capital Group, Qiming Venture Partners, C&D Emerging Investment, Shenzhen Credit Guarantee Group, Fengnian Capital — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Hugemed
- ·The full record, as it builds
Funding rounds
No funding rounds for Hugemed are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hugemed
Developer and manufacturer of medical devices intended to support clinical surgeries. The company's devices provide solutions in the field of endoscopy for clinical surgery, emergency, anesthesia, respiratory, pediatrics, ICU, operating room, ambulance, outdoor emergency, and other medical use cases, enabling healthcare providers to leverage disposable endoscopes for emergency cases.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2014
- Employees
- 216
- Website
- hugemed.net/
- Ownership
- Privately Held (backing)
Hugemed doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hugemed shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hugemed in its N-PORT filings yet. We sweep new filings monthly.